Clinical Trial Update: Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating anticoagulation in patients undergoing percutaneous coronary revascularization; the study (NCT02448550) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Kaiser Permanente | Conditions: Percutaneous Coronary Intervention | Phase 3 | Status: TERMINATED